Target intelligence / Profile preview

Solute carrier family 39 member 7 (SLC39A7)

Target
SLC39A7
Molecular classification
Transporter
01

Overview

Solute carrier family 39 member 7 (SLC39A7), commonly known as ZIP7, is a transmembrane zinc transporter primarily localized to the endoplasmic reticulum (ER) and Golgi apparatus membranes. It plays a critical role in maintaining cellular zinc homeostasis by facilitating the transport of zinc ions from these intracellular storage compartments into the cytosol. Cytosolic zinc release mediated by SLC39A7 acts as a signaling second messenger, activating downstream pathways such as AKT, mTOR, and MAPK that promote cell proliferation, growth, and survival.\n\nConsequently, SLC39A7 is frequently upregulated and hyperactivated in various malignancies, including breast, gastric, and colorectal cancers, where it contributes to tumor progression, metastasis, and endocrine therapy resistance. Additionally, SLC39A7 is essential for B-cell development, glycemic control in skeletal muscle, and protection against ER stress. Pharmacological targeting of SLC39A7 is an emerging therapeutic strategy, with small-molecule inhibitors like NVS-ZP7-4 and NVS-ZP7-7 being utilized to disrupt zinc homeostasis, induce ER stress, and selectively trigger apoptosis in cancer cells.

Other names
ZIP7Zrt- and Irt-like protein 7Histidine-rich membrane protein Ke4HKE4KE4RING5D6S115ED6S2244EAGM9
02

Biological functions

Zinc transportCellular zinc homeostasisSignal transductionCell proliferationCell growthApoptosisImmune responseB cell developmentGlucose metabolismMitophagyER stress regulation
03

Disease associations

CancerImmunodeficiencyInflammationDiabetes mellitusGastrointestinal disorderCardiovascular diseaseNeurodegenerative diseaseAsthma
04

Safety considerations

Endoplasmic reticulum (ER) stress inductionImpaired B cell developmentAgammaglobulinemiaImmunodeficiencyGlucose intoleranceInsulin resistanceEmbryonic lethality
05

Interacting drugs

1 more in the full profile.

06

Biomarkers

Phosphorylated ZIP7 (pS275/S276)SLC39A7 expression level

Beyond the preview

Go deeper on Solute carrier family 39 member 7 (SLC39A7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 39 member 7 (SLC39A7).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call